Matches in Wikidata for { <http://www.wikidata.org/entity/Q91703800> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q91703800 description "article scientifique publié en 2019" @default.
- Q91703800 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91703800 description "bài báo khoa học" @default.
- Q91703800 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91703800 description "scientific article published on 04 December 2019" @default.
- Q91703800 description "wetenschappelijk artikel" @default.
- Q91703800 description "наукова стаття, опублікована 4 грудня 2019" @default.
- Q91703800 name "When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival" @default.
- Q91703800 name "When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival" @default.
- Q91703800 type Item @default.
- Q91703800 label "When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival" @default.
- Q91703800 label "When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival" @default.
- Q91703800 prefLabel "When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival" @default.
- Q91703800 prefLabel "When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival" @default.
- Q91703800 P1433 Q91703800-7D2144F3-E029-48B5-B5AE-167A55699ADC @default.
- Q91703800 P1476 Q91703800-E8FA3FF5-1EF6-49A7-A289-815D1DCD4EC7 @default.
- Q91703800 P2860 Q91703800-6F5C8FC4-77F7-45ED-AF4C-F189A3B7AA2F @default.
- Q91703800 P31 Q91703800-CB61F0F9-3D57-4F1B-926D-ABADC2FD0FA6 @default.
- Q91703800 P356 Q91703800-C25CB269-CC06-41AC-B810-34254F3EDFEE @default.
- Q91703800 P50 Q91703800-25F7D3DE-A4B9-4A2A-B89A-7C8B92CE7C7E @default.
- Q91703800 P50 Q91703800-38CD8F76-EE63-4037-BDF7-1158E80A1806 @default.
- Q91703800 P50 Q91703800-B5AFA7E3-F799-4CE0-9A9E-80461113348F @default.
- Q91703800 P50 Q91703800-C64127A6-B5E4-45E4-851D-0C54D30EA418 @default.
- Q91703800 P50 Q91703800-CD6C8C0B-A81C-4D15-B497-485F8939ACC9 @default.
- Q91703800 P50 Q91703800-D970131D-A8FA-468C-91A5-75352DF9D834 @default.
- Q91703800 P577 Q91703800-2F19DDD3-62A8-4FB1-B19D-A480D01059D3 @default.
- Q91703800 P698 Q91703800-35E3B0F8-2987-4096-96C3-8102476AFC54 @default.
- Q91703800 P921 Q91703800-BBCC92A4-FE0B-4433-8ABD-156FDF0A6D52 @default.
- Q91703800 P356 AJCO.13287 @default.
- Q91703800 P698 31802642 @default.
- Q91703800 P1433 Q15757236 @default.
- Q91703800 P1476 "When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival" @default.
- Q91703800 P2860 Q27851406 @default.
- Q91703800 P31 Q13442814 @default.
- Q91703800 P356 "10.1111/AJCO.13287" @default.
- Q91703800 P50 Q56826384 @default.
- Q91703800 P50 Q73133055 @default.
- Q91703800 P50 Q82338106 @default.
- Q91703800 P50 Q90027483 @default.
- Q91703800 P50 Q90683070 @default.
- Q91703800 P50 Q91703793 @default.
- Q91703800 P577 "2019-12-04T00:00:00Z" @default.
- Q91703800 P698 "31802642" @default.
- Q91703800 P921 Q3658562 @default.